About Darbepoetin Alfa Injection
Step into the spotlight with Darbecon Darbepoetin Alfa Injection, the elite solution for managing anemia related to chronic kidney disease or chemotherapy. Each ace, top-notch, pre-filled 40 mcg/0.4 ml syringe delivers pristine quality and effectiveness, ensuring correction and maintenance of hemoglobin levels. Its administration route is both versatile and convenient-subcutaneous or intravenous. Take advantage of the trusted biotechnology expertise from Concord Biotech Limited. Intended for use under expert medical supervision, Darbecon offers a reliable biological approach to stimulate erythropoiesis in adults and children alike. Store between 2C-8C for optimal efficacy.
Surface of Application and Usage Highlights
Darbepoetin Alfa Injection is expertly formulated for subcutaneous or intravenous application, typically administered on the upper arm, abdomen, or thigh for subcutaneous injections, or directly into the bloodstream for intravenous use. This ace formulation is specifically recommended for the treatment of anemia arising from chronic kidney disease or as a result of chemotherapy. Its top-notch delivery system ensures accurate dosing for both adults and children, depending on physician directions and individual patient requirements.
FOB Port, Main Export and Domestic Markets
Darbepoetin Alfa Injection is available for global distribution, with key FOB ports situated throughout India. The asking price and sale price are tailored for bulk exporters, suppliers, and traders, enhancing competitive advantage in the export market. Main export destinations include Asia, Africa, and emerging pharmaceutical markets, while the product enjoys robust demand within the Indian domestic market, thanks to its pristine quality and trusted performance in anemia management.
FAQ's of Darbepoetin Alfa Injection:
Q: How should Darbepoetin Alfa Injection be administered safely?
A: Darbepoetin Alfa Injection must be administered either subcutaneously or intravenously as directed by a healthcare professional, ensuring the dose and method suit the patient's condition.
Q: What is the primary benefit of using Darbecon Darbepoetin Alfa Injection?
A: The main benefit is the correction and maintenance of hemoglobin levels, assisting in the treatment of anemia related to chronic kidney disease or chemotherapy.
Q: When is this injection recommended for use?
A: It is recommended when anemia is associated with chronic renal failure, whether the patient is on dialysis or not, or as a result of certain chemotherapy treatments.
Q: Where should Darbepoetin Alfa Injection be stored?
A: Store the pre-filled syringe at 2C-8C, ensuring it is never frozen and protected from direct light for maintaining product stability.
Q: What is the process for determining the right dosage?
A: Dosage of Darbepoetin Alfa is individualized based on the physician's prescription and tailored to each patient's hemoglobin needs and response.